These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 8675157)

  • 41. Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans.
    Loria P; Bozzoli M; Concari M; Guicciardi ME; Carubbi F; Bertolotti M; Piani D; Nistri A; Angelico M; Romani M; Carulli N
    Hepatology; 1997 Jun; 25(6):1306-14. PubMed ID: 9185744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
    O'Brien SM; Campbell GR; Burke AF; Maguire OC; Rowlands BJ; FitzGerald MX; Hegarty JE
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Semiquantitative measurement of lithocholic acid compounds in bile from patients with gallstones, before and during treatment with chenodeoxycholic acid.
    Arnfred T; Pedersen L
    Scand J Gastroenterol; 1976; 11(5):497-504. PubMed ID: 959764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Tea consumption and risk of biliary tract cancers and gallstone disease: a population-based case-control study in Shanghai, China].
    Zhang XH; Gao YT; Rashid A; Deng J; Liu EJ; Wu K; Sun L; Cheng JR; Gridley G; Hsing AW
    Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):667-71. PubMed ID: 16438888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of ursodeoxycholic acid on biliary bile acid and bile lipid composition in gallstone patients.
    Stiehl A; Raedsch R; Rudolph G; Walker S
    Hepatology; 1984; 4(1):107-11. PubMed ID: 6693062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavior of various cholesterol crystals in bile from patients with gallstones.
    Portincasa P; van Erpecum KJ; Jansen A; Renooij W; Gadellaa M; vanBerge-Henegouwen GP
    Hepatology; 1996 Apr; 23(4):738-48. PubMed ID: 8666327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum unconjugated primary and secondary bile acids in patients with cholangiocarcinoma and hepatocellular carcinoma.
    Changbumrung S; Tungtrongchitr R; Migasena P; Chamroenngan S
    J Med Assoc Thai; 1990 Feb; 73(2):81-90. PubMed ID: 2161896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of tauroursodeoxycholic acid on biliary lipid composition. A dose-response study.
    Muraca M; Vilei MT; Cianci V; Liu XT; Garotta F
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):391-3. PubMed ID: 7582394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
    Mazzella G; Rizzo N; Azzaroli F; Simoni P; Bovicelli L; Miracolo A; Simonazzi G; Colecchia A; Nigro G; Mwangemi C; Festi D; Roda E
    Hepatology; 2001 Mar; 33(3):504-8. PubMed ID: 11230728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biliary proteins and their redox status changes in gallstone patients.
    Grattagliano I; Wang DQ; Di Ciaula A; Diogo CV; Palasciano G; Portincasa P
    Eur J Clin Invest; 2009 Nov; 39(11):986-92. PubMed ID: 19656169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of gallbladder in gallstone formation.
    Nakayama F; van der Linden W
    Acta Chir Scand; 1974; 140(1):45-9. PubMed ID: 4819022
    [No Abstract]   [Full Text] [Related]  

  • 52. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic bile versus gallbladder bile: a comparison of protein and lipid concentration and composition in cholesterol gallstone patients.
    Keulemans YC; Mok KS; de Wit LT; Gouma DJ; Groen AK
    Hepatology; 1998 Jul; 28(1):11-6. PubMed ID: 9657090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kinetics and pool size of chenodeoxycholic acid in cholesterol gallstone patients.
    Pedersen L; Arnfred T
    Scand J Gastroenterol; 1975; 10(5):557-60. PubMed ID: 1153952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The mechanism of increased gallstone formation in obese human subjects.
    Mabee TM; Meyer P; DenBesten L; Mason EE
    Surgery; 1976 Apr; 79(4):460-8. PubMed ID: 1257908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver.
    Abate N; Carubbi F; Bozzoli M; Bertolotti M; Farah I; Rosi A; Carulli N
    Ital J Gastroenterol; 1994; 26(6):287-93. PubMed ID: 7949265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relative risk factors analysis of 3,922 cases of gallbladder cancer.
    Zou S; Zhang L
    Zhonghua Wai Ke Za Zhi; 2000 Nov; 38(11):805-8. PubMed ID: 11832168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abnormal biliary lipid composition in cystic fibrosis. Effect of pancreatic enzymes.
    Roy CC; Weber AM; Morin CL; Combes JC; Nusslé D; Mégevand A; Lasalle R
    N Engl J Med; 1977 Dec; 297(24):1301-5. PubMed ID: 917086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biliary bile acid concentration is a simple and reliable indicator for liver function after hepatobiliary resection for biliary cancer.
    Kurumiya Y; Nagino M; Nozawa K; Kamiya J; Uesaka K; Sano T; Yoshida S; Nimura Y
    Surgery; 2003 May; 133(5):512-20. PubMed ID: 12773979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcium in human gallbladder bile.
    Shiffman ML; Sugerman HJ; Kellum JM; Moore EW
    J Lab Clin Med; 1992 Dec; 120(6):875-84. PubMed ID: 1453109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.